您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2017, Vol. 55 ›› Issue (1): 60-62.doi: 10.6040/j.issn.1671-7554.0.2016.1534

• 临床医学 • 上一篇    下一篇

女性年龄对胚胎植入前遗传学诊断及筛查结局的影响

李昀,仲万霞,姚宁,胡双纲,刘洪卯   

  1. 上海交通大学医学院附属仁济医院生殖医学中心 上海市辅助生殖与优生重点实验室, 上海 200135
  • 收稿日期:2016-11-20 出版日期:2017-01-10 发布日期:2017-01-10
  • 通讯作者: 仲万霞. E-mail:zhongwanxia1982@163.com E-mail:zhongwanxia1982@163.com

Effects of female age on the outcome of preimplantation genetic diagnosis and screening

LI Yun, ZHONG Wanxia, YAO Ning, HU Shuanggang, LIU Hongmao   

  1. Center for Reproductive Medicine, Renji Hospital, Medical School of Shanghai Jiaotong University;
    Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai 200135, China
  • Received:2016-11-20 Online:2017-01-10 Published:2017-01-10

摘要: 目的 探讨女性年龄对胚胎植入前遗传学诊断及筛查(PGD/PGS)结局的影响。 方法 回顾性分析2015年1月1日至12月31日开展PGD/PGS治疗周期的149例患者,按女性年龄将患者分为3组:Ⅰ组10例(<25岁)共36枚囊胚;Ⅱ组94例(25~34岁)共329枚囊胚;Ⅲ组45例(≥35岁)共89枚囊胚。比较各组之间的胚胎正常率和临床妊娠率。 结果 Ⅰ组、Ⅱ组、Ⅲ组的胚胎正常率分别为50.00%、50.15%、29.21%。 Ⅰ组与Ⅲ组的胚胎正常率比较差异有统计学意义(χ=24.855, P<0.05),Ⅱ组与Ⅲ组的胚胎正常率比较差异有统计学意义(χ=212.376, P<0.05)。Ⅰ组、Ⅱ组、Ⅲ组的临床妊娠率分别为83.33%、82.50%、40.00%。 Ⅰ组与Ⅲ组的临床妊娠率比较差异有统计学意义(χ=23.893, P<0.05),Ⅱ组与Ⅲ组的临床妊娠率比较差异有统计学意义(χ=27.510, P<0.05)。 结论 女性年龄对PGD/PGS结局有影响,当女性年龄≥35岁时会明显降低胚胎的正常率和临床妊娠率。

关键词: 胚胎正常率, 女性年龄, 植入前遗传学诊断及筛查, 囊胚活检, 临床妊娠率

Abstract: Objective To investigate the female effects of age on the outcome of preimplantation genetic diagnosis and screening(PGD/PGS). Methods Clinical data of 149 patients who received PGD/PGS in our hospital during Jan. and Dec. 2015 were retrospectively reviewed. The patients were divided into 3 groups according to age: group Ⅰ(n=10, <25 years, 36 blastocysts), group Ⅱ(n=94, 25-34 years, 329 blastocysts), and group Ⅲ(n=45, ≥35 years, 89 blastocysts). The normal chromosome rate and clinical pregnancy rate of the three groups were compared. Results The normal chromosome rate in groups Ⅰ, Ⅱ and Ⅲ was 50.00%, 50.15% and 29.21%, respectively. There were statistical differences between groups Ⅰ and Ⅲ(χ=24.855, P<0.05), and groups Ⅱ and Ⅲ(χ=212.376, P<0.05). The clinical pregnancy rate in groups Ⅰ, Ⅱ and Ⅲ was 82.33%, 82.50% and 40.00%, respectively. There were statistical differences between groups Ⅰ and Ⅲ(χ=23.893, P<0.05), and groups Ⅱ and Ⅲ(χ=27.510, P<0.05). Conclusion The female age can affect the outcome of PGD/PGS. Age ≥35 years will significantly reduces the normal chromosome rate and clinical pregnancy rate.

Key words: Female age, Normal chromosome rate, Blastocyst biopsy, Clinical pregnancy rate, Preimplantation genetic diagnosis and screening

中图分类号: 

  • R715.5
[1] Girardet A, Viart V, Plaza S, et al. The improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis: toward an international consensus[J]. Eur J Hum Genet, 2016, 24(4): 469-478.
[2] Scott RT, Ferry K, Su J, et al. Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study[J]. Fertil Steril, 2012, 97(4): 870-875.
[3] 刘茜桐, 田莉, 师娟子, 等. 胚胎植入前遗传学诊断和筛查的研究进展[J]. 中国妇幼健康研究, 2016, 27(1): 123-126. LIU Xitong, TIAN Li, SHI Juanzi, et al. Research progression on preimplantation genetic diagnosis and screening[J]. Chinese Journal of Woman and Child Health Research, 2016, 27(1): 123-126.
[4] 张静, 吕睿, 吕永焕, 等. 胚胎植入前遗传学诊断和筛查的研究进展[J]. 国际生殖健康/计划生育杂志, 2015, 34(3): 243-247. ZHANG Jing, LÜ Rui, LÜ Yonghuan, et al. Research progress of preimplantation genetic diagnosis and screening[J]. Journal of International Reproductive Health/Family Planning, 2015, 34(3): 243-247.
[5] Tan YQ, Tan K, Zhang SP, et al. Single-nucleotide polymorphism microarray-based preimplantation genetic diagnosis is likely to improve the clinical outcome for translocation carriers[J]. Hum Reprod, 2013, 28(9): 2581-2592.
[6] 陈大蔚, 章志国, 邹薇薇, 等. 反复种植失败患者经植入前遗传学筛查获妊娠的研究[J/CD]. 中华临床医师杂志, 2015, 9(6):20-23. CHEN Dawei, ZHZNG Zhiguo, ZOU Weiwei, et al. Blastocyst preimplantation genetic screening(PGS)of a recurrent implantation failure(RIF)couple[J]. Chinese Journal of Clinicians(Electronic Edition), 2015, 9(6):20-23.
[7] Schoolcraft WB, Treff NR, Stevens JM, et al. Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and single-nucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients[J]. Fertil Steril, 2011, 96(3): 638-640.
[8] Scott RT, Upham KM, Forman EJ, et al. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial[J]. Fertil Steril, 2013, 100(3): 697-703.
[9] Fragouli E, Alfarawati S, Goodall N, et al. The cytogenetics of polar bodies: insights into female meiosis and the diagnosis of aneuploidy[J]. Mol Hum Reprod, 2011, 17(5): 286-295.
[10] Yang Z, Liu J, Collins GS, et al. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study[J]. Mol Cytogenet, 2012, 5(1): 24.
[11] Gardner DK, Sakkas D. Assessment of embryo viability: the ability to select a single embryo for transfer-a review[J]. Placenta, 2003, 24: S5-S12.
[12] Hodes-Wertz B, Grifo J, Ghadir S, et al. Idiopathic recurrent miscarriage is caused mostly by aneuploid embryos[J]. FertilSteril, 2012, 98(3): 675-680.
[13] Forman EJ, Tao X, Ferry KM, et al. Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates[J]. Hum Reprod, 2012, 27(4): 1217-1222.
[14] Fischer J, Colls P, Escudero T, et al. Preimplantation genetic diagnosis(PGD)improves pregnancy outcome for translocation carriers with a history of recurrent losses[J]. Fertil Steril, 2010, 94(1): 283-289.
[15] Kuliev A, Cieslak J, Ilkevitch Y, et al. Chromosomal abnormalities in a series of 6733 human oocytes in preimplantation diagnosis for age-related aneuploidies[J]. Reprod Biomed Online, 2003, 6(1): 54-59.
[16] Pellestor F, Andreo B, Arnal F, et al. Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes[J]. Hum Genet, 2003, 112(2): 195-203.
[17] Forman EJ, Hong KH, Ferry KM, et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial[J]. Fertil Steril, 2013, 100(1): 100-107.
[18] Ata B, Kaplan B, Danzer H, et al. Array CGH analysis shows that aneuploidy is not related to the number of embryos generated[J]. Reprod Biomed Online, 2012, 24(6): 614-620.
[19] Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening[J]. Fertil Steril, 2014, 101(3): 656-663.
[20] Tulay P, Gültomruk M, Fndıklı N, et al. PGD management scheme for older females with balanced translocations: do older females have less chance of balanced embryo transfer?[J]. Turk Ger Gynecol Assoc, 2016, 17(2): 91-95.
[1] . 比较基因组杂交技术的改进及其在产前诊断中的应用[J]. 山东大学学报(医学版), 2009, 47(7): 89-92.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!